Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab. Sugiyama Y, Naiki T, Morikawa T, Odagiri K, et al. Anticancer Res 2026;46:2187-2198.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sugiyama Y, Naiki T, Morikawa T, Odagiri K, et al. Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab. Anticancer Res 2026;46:2187-2198.
PMID: 41895757